Cancer Patients Stay Mentally Sharp During Chemotherapy

A recent study has found that a simple exercise routine and low-dose ibuprofen may help cancer patients stay mentally sharp during chemotherapy, reducing the symptoms of 'chemo brain' that affect up to 80% of patients.

The study, published in the journal CANCER, found that patients who followed a home-based exercise program showed significant improvements in attention and cognitive function compared to those who received a placebo. Low-dose ibuprofen also showed some cognitive benefits, although the effects were less consistent.

The study enrolled 86 cancer patients receiving chemotherapy who reported cognitive difficulties. Participants were randomly assigned to one of four groups for six weeks: exercise and low-dose ibuprofen, exercise and placebo, low-dose ibuprofen only, and placebo only.

After six weeks, patients in the exercise and placebo group performed significantly better on tests of attention than those in the placebo group. Participants who received only low-dose ibuprofen also showed greater improvement than placebo participants on measures of attention.

The study's findings have important implications for cancer patients undergoing chemotherapy. 'Chemo brain' can make everyday tasks harder, and can affect up to 80% of patients. The study suggests that simple interventions like exercise and low-dose ibuprofen may help reduce some of these cognitive challenges.

The study's results also highlight the importance of addressing the cognitive symptoms of chemotherapy. Cancer patients often experience a range of physical and emotional side effects during treatment, and cognitive impairment can be a significant challenge. By reducing the symptoms of 'chemo brain', cancer patients may be able to better manage their treatment and improve their overall quality of life.

While the study's findings are promising, more research is needed to confirm the results and better understand the effects of exercise and low-dose ibuprofen on cognitive function during chemotherapy. Larger Phase III clinical trials will be necessary to fully establish the benefits of these interventions.

In the meantime, cancer patients undergoing chemotherapy may want to consider incorporating exercise and low-dose ibuprofen into their treatment plan. Exercise can be a simple and effective way to reduce the symptoms of 'chemo brain', and low-dose ibuprofen may provide additional cognitive benefits. By taking a proactive approach to managing their cognitive health, cancer patients may be able to better navigate the challenges of chemotherapy and improve their overall well-being.